Compare Davita Inc (DVA) vs YieldMax NVDA Option Income Strategy ETF (NVDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while YieldMax NVDA Option Income Strategy ETF trades at $12.76 (market cap $1.46B). The key difference: Davita Inc is far larger — about 7.7× YieldMax NVDA Option Income Strategy ETF's market cap, and Davita Inc is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| DVA | NVDY | |
|---|---|---|
Market Cap | $11.28B | $1.46B |
Volume | 650,294 | 1,111,033 |
Sector | Health | Income / Options Overlay |
52-Week High | $240.96 | $17.21 |
52-Week Low | $103.87 | $11.58 |
Typical Hold Time | 113 Days | 43 Days |
Enterprise Value | $24.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
NVDY trades at $13.01, down 0.31% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF generates weekly dividends, averaging around $0.10 per share recently, reflecting its income-focused strategy tied to NVIDIA's stock volatility. However, key valuation ratios like P/E and P/S are unavailable, limiting fundamental clarity.
The outlook is mixed: strong dividend yields appeal to income seekers, but structural caps on upside participation and potential NAV erosion pose long-term risks. Analyst sentiment has shifted to hold due to declining volatility in NVIDIA, suggesting cautious optimism for income but limited growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →
